{"config":{"lang":["en"],"separator":"[\\s\\-]+","pipeline":["stopWordFilter"]},"docs":[{"location":"","title":"Welcome to the Research Archive of Casper M\u00f8ller Frederiksen, PhD","text":"<p>This site provides a comprehensive overview of the research contributions and publications by Casper M\u00f8ller Frederiksen. His work focuses on the intersection of hematology, data science, and molecular biology, aiming to improve patient outcomes through data-driven insights.</p>"},{"location":"#overview-of-research","title":"Overview of Research","text":"<p>Dr. Frederiksen's research portfolio is diverse, with a significant focus on data-driven hematology. His recent work involves creating large-scale data repositories for patients with lymphoid cancers to facilitate epidemiological, molecular, and data-driven research. This includes the application of machine learning and the development of medical artificial intelligence (mAI) to analyze complex datasets from nationwide registers and electronic health records.</p> <p>His earlier work spans several domains, including: * Infectious Diseases: Investigating virological responses to treatment in HIV patients, particularly focusing on co-infections and risk factors for treatment failure. * Molecular Biology: Identifying molecular phenotypes for bone marrow stromal cells and exploring the genetic basis of cancers through transcriptional profiling. * Oxidative Stress: Studying the effects of oxidative stress in astroglial cells.</p>"},{"location":"#quick-links","title":"Quick Links","text":"<ul> <li>About Me: Learn more about my professional background and affiliations.</li> <li>Publications: Browse a comprehensive list of my published work.</li> <li>Research Topics: Explore the key themes and projects of my research.</li> </ul>"},{"location":"about/","title":"About Casper M\u00f8ller Frederiksen, PhD","text":"<p>This page provides professional details for Casper M\u00f8ller Frederiksen.</p>"},{"location":"about/#professional-information","title":"Professional Information","text":"<ul> <li>Primary Affiliation: Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</li> <li>Additional Affiliation: Danish Cancer Institute, Copenhagen, Denmark.</li> <li>Past Affiliations:<ul> <li>Centre for Health and Infectious Disease Research (CHIP), Department of Infectious Diseases and Rheumatology, Rigshospitalet.</li> <li>Department of Endocrinology, Odense University Hospital, Odense C, Denmark.</li> <li>Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, DK-8200 Aarhus N, Denmark.</li> <li>Department of Life Sciences and Chemistry, Roskilde University, 4000 Roskilde, Denmark.</li> </ul> </li> </ul>"},{"location":"about/#research-focus","title":"Research Focus","text":"<p>Dr. Frederiksen's work integrates clinical data and advanced computational methods to address complex medical challenges. His expertise includes:</p> <ul> <li>Data-Driven Hematology</li> <li>Medical Artificial Intelligence (mAI)</li> <li>Large-Scale Clinical Databases</li> <li>HIV and Infectious Disease Epidemiology</li> <li>Genomic and Transcriptional Profiling</li> <li>Molecular Biology and Cellular Stress</li> </ul>"},{"location":"about/#competing-interests","title":"Competing Interests","text":"<ul> <li>Received funding from Octapharma during the conduct of the DALY-CARE study.</li> </ul>"},{"location":"publications/by_topic/","title":"Publications by Topic","text":"<p>This section categorizes publications based on their primary research theme.</p>"},{"location":"publications/by_topic/#hematology-and-data-driven-medicine","title":"Hematology and Data-Driven Medicine","text":"<ul> <li>Brieghel C, Werling M, Frederiksen CM, et al. (2025). The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology.<ul> <li>Summary: Details the creation and contents of the DALY-CARE data resource, a comprehensive national database for lymphoid cancer research in Denmark designed to foster epidemiological studies and the development of medical AI.</li> <li>DOI: 10.2147/CLEP.S479672</li> </ul> </li> </ul>"},{"location":"publications/by_topic/#infectious-diseases-hiv-cmv","title":"Infectious Diseases (HIV &amp; CMV)","text":"<ul> <li>Willemse S, Smit C, Sogni P, et al. (2019). Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis.<ul> <li>DOI: 10.1111/jvh.13146</li> </ul> </li> <li>Monge S, Mocroft A, Sabin A, et al. (2018). Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?<ul> <li>DOI: 10.1111/hiv.12536</li> </ul> </li> <li>Judd A, Lodwick R, Noguera-Julian A, et al. (2017). Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.<ul> <li>DOI: 10.1111/hiv.12411</li> </ul> </li> <li>De Luca A, Flandre P, Dunn D, et al. (2016). Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.<ul> <li>DOI: 10.1093/jac/dkv465</li> </ul> </li> <li>Mocroft A, Lundgren J, Antinori A, et al. (2015). Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.<ul> <li>DOI: 10.2807/1560-7917.ES.2015.20.47.30070</li> </ul> </li> <li>Lodding IP, Sengel\u00f8v H, da Cunha-Bang C, et al. (2015). Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections.<ul> <li>DOI: 10.1016/j.ebiom.2015.05.003</li> </ul> </li> <li>da Cunha-Bang C, Kirkby N, S\u00f8nderholm M, et al. (2013). The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection.<ul> <li>DOI: 10.1111/ajt.12042</li> </ul> </li> </ul>"},{"location":"publications/by_topic/#genomics-molecular-biology-cellular-stress","title":"Genomics, Molecular Biology &amp; Cellular Stress","text":"<ul> <li>Larsen KH, Frederiksen CM, Burns JS, et al. (2010). Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity.<ul> <li>DOI: 10.1359/jbmr.091018</li> </ul> </li> <li>Frederiksen CM, H\u00f8jlund K, Hansen L, et al. (2008). Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.<ul> <li>DOI: 10.1007/s00125-008-1122-9</li> </ul> </li> <li>MacKenzie ED, Selak MA, Tennant DA, et al. (2007). Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells.<ul> <li>DOI: 10.1128/MCB.01927-06</li> </ul> </li> <li>Frederiksen CM, Aaboe M, Dyrskj\u00f8t L, et al. (2003). Technical evaluation of cDNA microarrays.<ul> <li>(No DOI provided in source)</li> </ul> </li> <li>Frederiksen CM, Knudsen S, Laurberg S, et al. (2003). Classification of Dukes' B and C colorectal cancers using expression arrays.<ul> <li>DOI: 10.1007/s00432-003-0434-x</li> </ul> </li> <li>Birkenkamp-Demtroder K, Christensen LL, Olesen SH, et al. (2002). Gene expression in colorectal cancer.<ul> <li>(No DOI provided in source)</li> </ul> </li> <li>Thykjaer T, Workman C, Kruh\u00f8ffer M, et al. (2001). Identification of gene expression patterns in superficial and invasive human bladder cancer.<ul> <li>(No DOI provided in source)</li> </ul> </li> <li>Frederiksen CM, Clausen J. (1999). The effects of oxidative stress in in vitro cultured astroglial cells.<ul> <li>DOI: 10.1177/026119299902700307</li> </ul> </li> </ul>"},{"location":"publications/by_year/","title":"Publications by Year","text":""},{"location":"publications/by_year/#2025","title":"2025","text":"<ul> <li>Brieghel C, Werling M, Frederiksen CM, et al. (2025). The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology. Clin Epidemiol. 2025 Feb 20;17:131-145. doi: 10.2147/CLEP.S479672.<ul> <li>Summary: This paper details the creation of DALY-CARE, a large-scale data repository for lymphoid cancer patients in Denmark. It combines data from 10 nationwide registers, electronic health records, and laboratory results to create a secure research environment for developing data-driven hematology, including medical AI tools.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2019","title":"2019","text":"<ul> <li>Willemse S, Smit C, Sogni P, et al. (2019). Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis. J Viral Hepat. 2019 Oct;26(10):1224-1228. doi: 10.1111/jvh.13146.<ul> <li>Summary: This study, with C.M. Frederiksen as a listed collaborator, investigated adherence to screening guidelines for hepatocellular carcinoma in HIV patients co-infected with hepatitis B or C. (Abstract not provided in source text).</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2018","title":"2018","text":"<ul> <li>Monge S, Mocroft A, Sabin A, et al. (2018). Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? HIV Med. 2018 Jan;19(1):42-48. doi: 10.1111/hiv.12536.<ul> <li>Summary: This study evaluated differences in immunovirological response to cART between migrant and native populations in Western Europe. It found that response varies by geographical origin and sex, with migrants from sub-Saharan Africa starting treatment with lower CD4 counts and some groups experiencing lower virological response rates.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2017","title":"2017","text":"<ul> <li>Judd A, Lodwick R, Noguera-Julian A, et al. (2017). Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV Med. 2017 Mar;18(3):171-180. doi: 10.1111/hiv.12411.<ul> <li>Summary: This study found that teenagers with perinatally acquired HIV have higher rates of triple-class virological failure compared to young adults infected heterosexually. Predictors for failure included being aged 10-14 at ART start, African origin, and NNRTI-based initial regimens.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2016","title":"2016","text":"<ul> <li>De Luca A, Flandre P, Dunn D, et al. (2016). Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. J Antimicrob Chemother. 2016 May;71(5):1352-60. doi: 10.1093/jac/dkv465.<ul> <li>Summary: The study developed and validated a new weighted mutation score to predict virological response to darunavir in patients with HIV-1. This new model outperformed existing genotypic resistance interpretation systems for both B and non-B HIV subtypes.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2015","title":"2015","text":"<ul> <li>Mocroft A, Lundgren J, Antinori A, et al. (2015). Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20(47). doi: 10.2807/1560-7917.ES.2015.20.47.30070.<ul> <li>Summary: An update on late presentation (LP) for HIV care across Europe from 2010-2013, showing that LP remains a significant issue with nearly half of individuals presenting with a low CD4 count or an AIDS-defining event. The study calls for improved HIV testing strategies, especially for vulnerable groups.</li> </ul> </li> <li>Lodding IP, Sengel\u00f8v H, da Cunha-Bang C, et al. (2015). Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections. EBioMedicine. 2015 Jul;2(7):699-705. doi: 10.1016/j.ebiom.2015.05.003.<ul> <li>Summary: This study re-evaluated the replication kinetics of CMV in transplant recipients, finding a median doubling time of 4.3 days, longer than previously reported. This suggests that screening intervals for pre-emptive therapy can be safely extended in cohorts with similar CMV doubling times.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2013","title":"2013","text":"<ul> <li>da Cunha-Bang C, Kirkby N, S\u00f8nderholm M, et al. (2013). The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection. Am J Transplant. 2013 Feb;13(2):458-66. doi: 10.1111/ajt.12042.<ul> <li>Summary: This study investigated the clinical impact of ganciclovir-related mutations (GRMs) in the CMV-UL97 gene. It proposed a categorization of GRMs and found that specific \"Signature\" GRMs were strongly associated with an excess risk of treatment failure.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2010","title":"2010","text":"<ul> <li>Larsen KH, Frederiksen CM, Burns JS, et al. (2010). Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J Bone Miner Res. 2010 Apr;25(4):796-808. doi: 10.1359/jbmr.091018.<ul> <li>Summary: Using DNA microarrays, this study identified a molecular signature predictive of the in vivo bone-forming capacity of human bone marrow stromal cells (BMSCs).</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2008","title":"2008","text":"<ul> <li>Frederiksen CM, H\u00f8jlund K, Hansen L, et al. (2008). Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia. 2008 Nov;51(11):2068-77. doi: 10.1007/s00125-008-1122-9.<ul> <li>Summary: This study examined gene expression in myotubes from patients with type 2 diabetes and found no evidence for differential expression of genes involved in mitochondrial oxidative metabolism, supporting the hypothesis that impaired mitochondrial biogenesis is not a primary defect causing insulin resistance.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2007","title":"2007","text":"<ul> <li>MacKenzie ED, Selak MA, Tennant DA, et al. (2007). Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol. 2007 May;27(9):3282-9. doi: 10.1128/MCB.01927-06.<ul> <li>Summary: This research designed cell-permeating derivatives of alpha-ketoglutarate to counteract the \"pseudohypoxia\" induced by deficiencies in the TCA cycle enzymes SDH and FH, suggesting a new therapeutic strategy for associated cancers.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2003","title":"2003","text":"<ul> <li>Frederiksen CM, Aaboe M, Dyrskj\u00f8t L, et al. (2003). Technical evaluation of cDNA microarrays. APMIS Suppl. 2003;(109):96-101.<ul> <li>Summary: This study evaluated the technical performance of cDNA microarrays with a limited number of spots, concluding they are of high technical quality and that LOWESS normalization is suitable for minimizing variation.</li> </ul> </li> <li>Frederiksen CM, Knudsen S, Laurberg S, et al. (2003). Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol. 2003 May;129(5):263-71. doi: 10.1007/s00432-003-0434-x.<ul> <li>Summary: The study used gene expression microarrays to classify colorectal tumors, demonstrating that it is possible to classify Dukes' B and C samples with less than 20% error.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2002","title":"2002","text":"<ul> <li>Birkenkamp-Demtroder K, Christensen LL, Olesen SH, et al. (2002). Gene expression in colorectal cancer. Cancer Res. 2002 Aug 1;62(15):4352-63.<ul> <li>Summary: Using oligonucleotide microarrays, this research identified 226 known genes and 157 ESTs highly relevant for colorectal cancer (CRC), providing potential new tumor markers and therapeutic targets.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2001","title":"2001","text":"<ul> <li>Thykjaer T, Workman C, Kruh\u00f8ffer M, et al. (2001). Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res. 2001 Mar 15;61(6):2492-9.<ul> <li>Summary: This study used oligonucleotide arrays to establish gene expression patterns for superficial and invasive bladder tumors, offering a basis for molecular classification.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#1999","title":"1999","text":"<ul> <li>Frederiksen CM, Clausen J. (1999). The effects of oxidative stress in in vitro cultured astroglial cells. Altern Lab Anim. 1999 May-Jun;27(3):351-7. doi: 10.1177/026119299902700307.<ul> <li>Summary: This study showed that astroglial cells metabolize paraquat, leading to the generation of free radicals and dose-dependent DNA fragmentation.</li> </ul> </li> </ul>"},{"location":"research/daly_care/","title":"The DALY-CARE Project","text":""},{"location":"research/daly_care/#the-danish-lymphoid-cancer-research-daly-care-data-resource","title":"The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource","text":"<p>The DALY-CARE project represents a foundational effort to establish a new paradigm of data-driven hematology in Denmark.</p> <p>Publication: The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology.</p>"},{"location":"research/daly_care/#aim-and-background","title":"Aim and Background","text":"<p>The primary aim of the DALY-CARE project is to create a large-scale, comprehensive data repository for all patients with lymphoid-lineage cancers (LC) in Denmark. Historically, research in medical artificial intelligence (mAI) has been hampered by a lack of access to large, shared datasets. The DALY-CARE resource was created to address this gap, enabling advanced research into cancers that share numerous epidemiological and clinical features, making them ideal for meta-learning approaches.</p>"},{"location":"research/daly_care/#methods-and-scale","title":"Methods and Scale","text":"<p>The project involved an extensive data gathering effort, using open-source pipelines to create a resource approved for epidemiological, molecular, and data-driven research. It successfully integrated data for all Danish adults registered with LC diagnoses since 2002, totaling 65,774 patients.</p> <p>The resource combines data from: * 10 nationwide Danish registers * Electronic Health Records (EHR) * Nationwide laboratory data</p> <p>This vast amount of information is hosted on a high-powered cloud-computer platform, creating a secure and powerful research environment.</p>"},{"location":"research/daly_care/#data-contents","title":"Data Contents","text":"<p>The DALY-CARE resource is exceptionally rich, containing millions of data points across numerous domains, including:</p> <ul> <li>Treatments: 21,750 cytoreductive treatment plans, 21.3 million outpatient prescriptions, and 12.7 million in-hospital administrations.</li> <li>Biochemistry: 77.3 million biochemical analyses.</li> <li>Diagnoses: 14.8 million ICD-10 comorbidity codes.</li> <li>Pathology: 4.5 million pathology codes.</li> <li>Procedures: 8.3 million treatment procedures and 1.0 million surgical procedures.</li> <li>Imaging: 3.3 million radiological examinations.</li> <li>Vitals: 18.3 million vital sign values.</li> <li>Outcomes: Comprehensive survival data.</li> </ul>"},{"location":"research/daly_care/#conclusion-and-impact","title":"Conclusion and Impact","text":"<p>The DALY-CARE data resource is a transformative tool for hematological research. It enables a wide range of studies, from molecular analyses to real-world evidence evaluation of care efficacy.</p> <p>Most importantly, it serves as the basis for developing and deploying near real-time decision-support tools and other mAI applications directly into clinical EHR systems. This allows for the extrapolation of clinical trial results to real-world practice, with the ultimate goal of improving care for patients with lymphoid cancers and streamlining health data infrastructure across medicine.</p>"},{"location":"research/statistics/","title":"Research Statistics","text":"<p>This page presents a quantitative overview of Dr. Frederiksen's publication record based on the available data.</p>"},{"location":"research/statistics/#publication-count","title":"Publication Count","text":"<ul> <li>Total Publications (from provided list): 12<ul> <li>Note: This count is based on a specific PubMed export and may not be exhaustive.</li> </ul> </li> </ul>"},{"location":"research/topics/","title":"Research Topics","text":"<p>Dr. Frederiksen's research bridges clinical medicine with data science and molecular biology. The primary focus areas are detailed below.</p>"},{"location":"research/topics/#data-driven-hematology-and-medical-ai","title":"Data-Driven Hematology and Medical AI","text":"<p>A central theme of the current research is the development of \"data-driven hematology\". This involves leveraging large, nationwide health datasets to advance the understanding and treatment of hematological cancers. The goal is to create a framework where meta-learning and medical artificial intelligence (mAI) can be applied to complex patient data, a field that has been limited by the lack of large, shared datasets. By creating open-source processing pipelines and a secure cloud-computing environment, this research aims to build tools that can be deployed directly into EHR systems, providing near real-time decision support for clinicians.</p>"},{"location":"research/topics/#cancer-genomics-and-molecular-classification","title":"Cancer Genomics and Molecular Classification","text":"<p>Early work focused on using microarray technology to understand the molecular basis of cancer. This involved large-scale gene expression profiling to: * Classify Tumors: Differentiate between stages of colorectal and bladder cancer based on unique transcriptional signatures. This work demonstrated that molecular classification of common cancers was becoming a reality. * Identify Biomarkers: Pinpoint new potential tumor markers and therapeutic targets by identifying genes that are consistently up- or down-regulated in tumor tissue compared to normal tissue. A key finding was the consistent down-regulation of 15 nuclear-encoded mitochondrial proteins in colorectal cancer.</p>"},{"location":"research/topics/#infectious-disease-epidemiology-in-vulnerable-populations","title":"Infectious Disease Epidemiology in Vulnerable Populations","text":"<p>As a collaborator in large European cohorts like COHERE, Dr. Frederiksen contributed to major studies on HIV and other viral infections. This research has explored: * Treatment Response Disparities: Investigating why immunological and virological responses to antiretroviral therapy differ between migrant and native populations in Europe. * Virological Failure: Identifying risk factors for treatment failure in specific populations, such as teenagers with perinatally acquired HIV. * Viral Resistance: Developing improved methods for predicting viral resistance to specific drugs, such as darunavir, and understanding the clinical impact of resistance mutations in CMV infections post-transplant.</p>"},{"location":"research/topics/#cellular-stress-and-metabolism","title":"Cellular Stress and Metabolism","text":"<p>Research at the cellular level has investigated fundamental biological processes and their role in disease. This includes: * Metabolic Dysfunction in Disease: Studying the link between TCA cycle dysfunction, \"pseudohypoxia,\" and cancer, leading to the design of novel therapeutic compounds. * Primary Defects in Type 2 Diabetes: Using transcriptional profiling to test the hypothesis that impaired mitochondrial biogenesis is a primary, inherited defect in type 2 diabetes, with findings suggesting it is not. * Oxidative Stress: Examining how xenobiotics can induce oxidative stress and DNA damage in astroglial cells, providing insight into the cellular effects of free radicals.</p>"}]}